TerrAscend (TSNDF) Asset Writedowns and Impairment (2021 - 2026)

TerrAscend (TSNDF) reported Asset Writedowns and Impairment of $239000.0 for Q1 2026, down 50.21% year-over-year from $480000.0 in Q1 2025, and down 64.7% quarter-over-quarter from $677000.0 in Q4 2025.

TerrAscend (TSNDF) Asset Writedowns and Impairment (2021 - 2026) Analysis & Trends

TerrAscend (TSNDF) has 6 years of Asset Writedowns and Impairment data on file, last reported at $239000.0 in Q1 2026.

  • Asset Writedowns and Impairment for Q1 2026 came in at $239000.0, down 50.21% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.4 million (down 70.56% YoY), and the FY2025 annual result was $1.7 million, down 45.48% from the prior year.
  • Asset Writedowns and Impairment declined to $239000.0 in Q1 2026 per TSNDF's latest filing, from $677000.0 in the prior quarter.
  • Over five years, Asset Writedowns and Impairment peaked at $152.9 million in Q3 2022 and troughed at -$154.0 million in Q4 2022.
  • A 5-year average of $575470.6 and a median of $314000.0 in 2025 frame the typical range for Asset Writedowns and Impairment.
  • On a YoY basis, Asset Writedowns and Impairment climbed as much as 39314.43% in 2022 and fell as far as 5786.23% in 2022.
  • A 5-year view of Asset Writedowns and Impairment shows it stood at -$154.0 million in 2022, then surged by 99.53% to -$728000.0 in 2023, then surged by 675.55% to $4.2 million in 2024, then plunged by 83.84% to $677000.0 in 2025, then plunged by 64.7% to $239000.0 in 2026.
  • Business Quant data shows TSNDF's Asset Writedowns and Impairment at $239000.0 in Q1 2026, $677000.0 in Q4 2025, and $314000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 TerrAscend - - 34.60 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 239,000.00
Mar 31, 2026 239,000.00
Dec 31, 2025 677,000.00
Dec 31, 2025 677,000.00
Sep 30, 2025 314,000.00
Sep 30, 2025 314,000.00
Jun 30, 2025 193,000.00
Jun 30, 2025 193,000.00
Mar 31, 2025 480,000.00
Mar 31, 2025 480,000.00
Dec 31, 2024 4.19 Mn
Dec 31, 2024 4.19 Mn
Sep 30, 2024 183,000.00
Sep 30, 2024 183,000.00
Jun 30, 2024 -20,000.00
Jun 30, 2024 -20,000.00
Mar 31, 2024 2.44 Mn
Mar 31, 2024 2.44 Mn
Dec 31, 2023 -728,000.00
Dec 31, 2023 -728,000.00